Total Visits

Views
Newly designed hemagglutinin-Der p 2 chimera is a potential candidate for allergen specific immunotherapy63

Total Visits Per Month

April 2021May 2021June 2021July 2021August 2021September 2021October 2021
Newly designed hemagglutinin-Der p 2 chimera is a potential candidate for allergen specific immunotherapy92057763

File Visits

Views
512.pdf32

Top country views

Views
United States50
Serbia5
Iran4
Germany3
Sweden1

Top cities views

Views
Ashburn5
Belgrade5